✦ LIBER ✦

Cytotoxic natural antibodies against human tumours: An option for anti-cancer immunotherapy?

✍ Scribed by Reinhard Schwartz-Albiez; Simon Laban; Stefan Eichmüller; Michael Kirschfink

Book ID: 113482001
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 172 KB
Volume: 7
Category: Article
ISSN: 1568-9972
DOI: 10.1016/j.autrev.2008.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cancer process as a type of immunoco

The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: proposals for tumour immunotherapy and vaccine

✍ G. Manzo 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Peptide-antibody conjugates for tumour t

Peptide-antibody conjugates for tumour therapy: A MHC-class-II-restricted tetanus toxin peptide coupled to an anti-IG light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells

✍ Zhiwei Yu; Frank Healy; Danila Valmori; Patricia Escobar; Giampietro Corradin; J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 729 KB

Anti-idiotype antibody therapy of B-cell lymphomas, despite numerous promising experimental and clinical studies, has so far met with limited success. Tailor-made monoclonal antiidiotype antibodies have been injected into a large series of lymphoma patients, with a few impressive complete tumour rem